Investor Resources Home

At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to already-approved pharmacological agents.
HRTX (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$14.50
Change (%)0.00 (0.00%)
Volume0
Data as of 06/26/17 4:00 p.m. ET
Refresh quote

Corporate Presentation

DateTitle
05/16/17
Download Documentation Company Update (May)

Recent News

More >>
DateTitle 
05/30/17Heron Therapeutics to Present at the Jefferies 2017 Healthcare ConferencePrinter Friendly Version
05/10/17Heron Therapeutics Reports Financial Results for the Three Months Ended March 31, 2017 and Recent Corporate ProgressPrinter Friendly Version
05/09/17Heron Therapeutics to Present at the Bank of America Merrill Lynch 2017 Healthcare ConferencePrinter Friendly Version
04/24/17Heron Therapeutics Appoints Robert E. Hoffman as Chief Financial Officer and Senior Vice President, FinancePrinter Friendly Version

Upcoming Events

More >>

There are currently no events scheduled.

Data provided by NASDAQ. Minimum 15 minutes delayed.